Bayesian Capital Management’s Relay Therapeutics RLAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-43,900	Closed	-$286K	–	986
2024 Q2	$286K	Buy	43,900 +5,300	+14%	+$34.6K	0.03%	516
2024 Q1	$320K	Buy	+38,600	New	+$320K	0.03%	541
2023 Q2	–	Sell	-30,500	Closed	-$502K	–	1021
2023 Q1	$502K	Buy	+30,500	New	+$502K	0.06%	390